See if a new tomosynthesis imaging tool helps diagnose MSK issues in ED and clinic
Official title: Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different Diseases
Run by Nano-X Imaging · NCT07900412 · Data updated 2026-11-12
This study tests whether the Nanox.ARC Digital Tomosynthesis system can add diagnostic value for adults with suspected MSK problems and potentially reduce the need for CT or MRI.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Nano-X Imaging Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 1 site (Kfar Saba) |
| Status | Recruiting |
| Started | October 20, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | August 1, 2027 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT07900412 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with suspected or confirmed MSK pathology who have recently had plain radiography and are referred for or have undergone CT/MRI within the past 7 days.
✕Probably not a fit
Patients for whom DTS does not add diagnostic information or who require immediate CT/MRI for urgent management may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-arm study evaluating the diagnostic performance of the Nanox.ARC Digital Tomosynthesis system in adults with suspected or confirmed musculoskeletal pathology presenting to the emergency department or orthopedic clinics. Participants undergo a DTS scan in addition to standard radiography, with the goal of seeing if DTS provides additional clinically relevant information and could lower the future need for CT or MRI. The system is FDA-cleared and CE-marked as an adjunct to radiography, and the study will be conducted in real-world clinical settings at Meir Medical Center, Israel. Outcomes focus on incremental diagnostic information and potential reductions in radiation exposure and healthcare costs. Eligible participants are adults who have had a plain radiograph within 7 days and are undergoing or scheduled for further imaging.
Why it matters
Potential benefit: If successful, DTS could improve diagnostic clarity for MSK conditions and reduce the need for higher-dose imaging like CT or MRI.
How similar studies have gone: Prior studies of digital tomosynthesis in MSK imaging have shown potential diagnostic advantages in certain settings, but this approach remains exploratory in this specific context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female patients aged 18 years or older. 2. Ability and willingness to read, understand, and sign the Informed Consent Form (ICF). 3. Clinical status: has undergone a conventional radiograph with or without advanced imaging (CT/MRI) within the past 7 days for a suspected or confirmed MSK pathology; OR is referred to undergo advanced imaging (CT/MRI) or an additional radiograph within the same 7-day timeframe, in the presence of an available radiograph. 4. Negative pregnancy test (for women under the age of 50). Exclusion Criteria: 1. Cases in which a delay caused by participation in the study could negatively impact the patient's clinical condition or pose a risk to their health or life. 2. Pregnant or breastfeeding women. 3. Body weight exceeding 150 kg. 4. Inability to cooperate with the study procedures or to maintain the required position during the DTS scan.
Where it's running
-
Meir Medical Center5
Kfar Saba, Israel Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
REMS testing for osteoporosis diagnosis and fracture risk in adults compared with DXA
This study tests whether REMS can diagnose osteoporosis and predict fracture risk in adults who are being evaluated for bone health, using DXA as the standard reference.
-
See how well iFuse TORQ TNT works for pelvic fragility fractures
This study tests the iFuse TORQ TNT implant in older adults with pelvic fragility fractures to see if real-world use leads to better outcomes.
-
Buprenorphine for pain relief in older adults with broken bones in the ED
This study tests whether buprenorphine can safely and effectively relieve pain in older adults with acute fractures, compared with hydromorphone.
-
Cannabidiol for pain relief after traumatic fractures and to reduce opioid use
We will test whether taking cannabidiol twice daily for one month can reduce pain and opioid use in adults 18–70 treated for recent long-bone fractures at Sacré-Coeur Hospital.
-
Observing outcomes of the Medacta Shoulder System
This study is looking at how well the Medacta Shoulder System works and its safety for people with different shoulder problems.
-
Comparing oral and intravenous antibiotics for treating infected nonunion of fractures
This study is testing whether taking antibiotics by mouth works as well as getting them through an IV for people with infected fractures that haven't healed properly after surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.